text.skipToContent text.skipToNavigation

 IMPORTANT UPDATE:  Some items may be delayed in shipping or out of stock due to extremely high demand.

Corning® Supersomes™ Human CYP2C19 + Oxidoreductase, 0.5 nmol

Product Number 456219

Corning® Supersomes™ Human CYP2C19 + Oxidoreductase, 0.5 enzyme prepared from insect cells infected with baculovirus containing desired cDNAs

CYP2C19 metabolizes 5-10% of prescribed medications. CYP2C19 drug substrates include omeprazole, lansoprazole, pantoprazole, phenytoin, diazepam, and S-mephenytoin (4′-hydroxylation, probe substrate/activity). CYP2C19 is responsible for the (S)-mephenytoin 4′-hydroxylase polymorphism. Approximately 20% of Asians are deficient in CYP2C19 activity (due to two prevalent allelic variants: *2 and *3, which result in inactive protein.

  • Contains Human Oxidoreductase, but not cytochrome b₅
  • Available size: 0.5 nmole P450 in 0.5 mL
  • Protein concentration: Available in batch data sheet. Contact Corning Scientific support to obtain the information.

This product is non-returnable. If you have any questions, please contact us immediately.

$157.83 per each

In Stock

Product Number   456219
Qty./Pk   1 / Pk  
Qty./Cs   1 / Ea  
Brand   Corning®  
Size   0.5 nmol  
Species   Human  
Enzyme Type   P450  
Protein Concentration   Lot-dependent  
Storage   -80°C  
Cellular Location   Microsome  
Specifications Documents